Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01765309 · ClinicalTrials.gov registry record · NA

A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders

A NA study of Breast Cancer, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT01765309 is a NA study of Breast Cancer that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01765309, a NA study of Breast Cancer, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Investigation of whether injection of the pectoralis muscle with 100 units botulinum toxin during breast reconstruction with tissue expanders results in decreased pain using a blinded, randomized, controlled trial.

Conditions Studied

Interventions

  • PROCEDURE Bilateral mastectomy with reconstruction

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2009-03
Est. Completion 2012-07
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01765309

The ClinicalTrials.gov registry entry for NCT01765309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Bilateral mastectomy with reconstruction is the first listed.

NCT01765309 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01765309 about?

NCT01765309 is a clinical study titled "A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders". Investigation of whether injection of the pectoralis muscle with 100 units botulinum toxin during breast reconstruction with tissue expanders results in decreased pain using a blinded, randomized, controlled trial.

What is the current status of trial NCT01765309?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2009-03. Estimated completion is 2012-07.

What conditions does trial NCT01765309 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01765309?

The interventions under investigation include: Bilateral mastectomy with reconstruction (PROCEDURE).

Who is sponsoring clinical trial NCT01765309?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01765309 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.